Lyrica (U.S. Pharmaceuticals)
Welcome to the PulseAid listing for the Lyrica drug offered from U.S. Pharmaceuticals. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | U.S. Pharmaceuticals |
NON-PROPRIETARY NAME: | PREGABALIN |
SUBSTANCE NAME: | PREGABALIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2004-12-30 |
END MARKETING DATE: | 0000-00-00 |
Lyrica HUMAN PRESCRIPTION DRUG Details:
Item Description | Lyrica from U.S. Pharmaceuticals |
LABELER NAME: | U.S. Pharmaceuticals |
DEA SCHEDULE: | CV
|
ACTIVE STRENGTH: | 50(mg/1) |
START MARKETING DATE: | 2004-12-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63539-013_97ad1752-d9b5-460f-b49c-c7551e70f07e |
PRODUCT NDC: | 63539-013 |
APPLICATION NUMBER: | NDA021724 |
Other PREGABALIN Pharmaceutical Manufacturers / Labelers: